Literature DB >> 8987248

Anti-cytochrome P450 autoantibodies in drug-induced disease.

P H Beaune1, S Lecoeur, M Bourdi, A Gauffre, C Belloc, P Dansette, D Mansuy.   

Abstract

Drugs may induce hepatitis through immune mechanisms. In this review we have used the examples of 2 drugs to elucidate the first steps leading to the triggering of such disease, namely tienilic acid (TA) and dihydralazine (DH). These drugs are transformed into reactive metabolite(s) by cytochrome P450 (2C9 for TA and 1A2 for DH) (step 1). The reactive metabolites produced are very short-lived and bind directly to the enzymes which generated them (step 2). A neoantigen is thus formed which triggers an immune response (step 3), characterized by the presence of autoantibodies in the patient's serum (step 4). The autoantibodies are directed against the cytochrome P450 which generated the metabolite(s). Although the process by which TA and DH induce-hepatitis has been elucidated, further studies are necessary to generalize this mechanism. In addition, an animal model will also be useful to fully understand the immune mechanism of this type of disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987248     DOI: 10.1111/j.1600-0609.1996.tb01652.x

Source DB:  PubMed          Journal:  Eur J Haematol Suppl        ISSN: 0902-4506


  7 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

Review 3.  Metabolism considerations for kinase inhibitors in cancer treatment.

Authors:  Derek R Duckett; Michael D Cameron
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

4.  Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways.

Authors:  Xiaohai Li; Yuanjun He; Claudia H Ruiz; Marcel Koenig; Michael D Cameron; Tomas Vojkovsky
Journal:  Drug Metab Dispos       Date:  2009-03-12       Impact factor: 3.922

5.  Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

Authors:  Raj Vuppalanchi; Raghavender Gotur; K Rajender Reddy; Robert J Fontana; Marwan Ghabril; Andrzej S Kosinski; Jiezhun Gu; Jose Serrano; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-20       Impact factor: 11.382

6.  Xenobiotic exposure and autoimmune hepatitis.

Authors:  Kathleen M Gilbert
Journal:  Hepat Res Treat       Date:  2010-12-30

Review 7.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.